Trichomonas vaginalis:: In vitro attachment and internalization of HIV-1 and HIV-1-infected lymphocytes

被引:22
|
作者
Rendón-Maldonado, J
Espinosa-Cantellano, M
Soler, C
Torres, JV
Martínez-Palomo, A
机构
[1] IPN, Dept Expt Pathol, Ctr Invest & Estudios Avanzados, Mexico City 07360, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Res Unit Human Retroviruses, Inst Invest Biomed, Mexico City 04510, DF, Mexico
[3] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA
关键词
HIV infection; immunofluorescence; protozoan infections; sexually transmitted diseases; transmission electron microscopy; trichomoniasis;
D O I
10.1111/j.1550-7408.2003.tb00104.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Sexually transmitted diseases (STDs) caused by bacteria and protozoa play an important role in the epidemiology of human immunodeficiency virus (HIV-1) infection. Human trichomoniasis, produced by the protozoan parasite Trichomonas vaginalis, is one of the most common STDs, and is a cause of mucosal lesions in the urogenital tract, which may increase the risk for HIV infection. However, there a re no reports concerning the outcome of in vitro interactions between HIV particles and trichomonads. Therefore, we incubated T vaginalis with three subtypes of HIV-1 (A, B, and D), as well as with HIV-1-infected lymphocytes, and analyzed the interactions with immunofluorescence microscopy and transmission electron microscopy. Our results demonstrated that HIV-1 particles attach and are incorporated into T vaginalis through endocytic vesicles and are degraded within cytoplasmic vacuoles in approximately 48 h. There was no ultrastructural evidence of HIV-1 replication in trichomonads. These results demonstrated that trichomonads may internalize and harbor HIV-1 particles for short periods of time. In addition, under in vitro conditions, T. vaginalis ingests and digests HIV-1-infected lymphocytes.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 50 条
  • [41] Trends in human immunodeficiency virus type 1 (HIV-1) load among HIV-1-infected children with hemophilia
    Engels, EA
    Rosenberg, PS
    Katki, H
    Goedert, JJ
    Biggar, RJ
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03): : 364 - 368
  • [42] Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients
    Moja, P
    Tranchat, C
    Tchou, I
    Pozzetto, B
    Lucht, F
    Desgranges, C
    Genin, C
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05): : 1607 - 1613
  • [43] Intrusive HIV-1-infected cells
    Dominika Rudnicka
    Olivier Schwartz
    Nature Immunology, 2009, 10 : 933 - 934
  • [44] Lipodystrophy in HIV-1-infected patients
    Domingo, P
    Pérez, A
    Torres, OH
    Montiel, JA
    Vázquez, G
    LANCET, 1999, 354 (9181): : 868 - 868
  • [45] MICROSPORIDIOSIS IN HIV-1-INFECTED INDIVIDUALS
    BLANSHARD, C
    GAZZARD, BG
    LANCET, 1991, 337 (8755): : 1488 - 1489
  • [46] Uncovering HIV-1-infected cells
    Veillette, Maxime
    Richard, Jonathan
    Finzi, Andres
    ONCOTARGET, 2015, 6 (26) : 21791 - 21792
  • [47] Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication:: Implications for the sexual transmission of HIV-1
    Guenthner, PC
    Secor, WE
    Dezzutti, CS
    INFECTION AND IMMUNITY, 2005, 73 (07) : 4155 - 4160
  • [48] IN-VITRO SYNTHESIS OF ANTIBODIES TO TOXOPLASMA-GONDII BY LYMPHOCYTES FROM HIV-1-INFECTED PATIENTS
    VENDRELL, JP
    REYNES, J
    HUGUET, MF
    NGOU, J
    MICHARD, C
    ATOUI, N
    PRATLONG, F
    SEGONDY, M
    SERRE, A
    LANCET, 1993, 342 (8862): : 22 - 23
  • [49] Evaluation of the Aptima® HIV-1 Quant Dx Assay for HIV-1 RNA Viral Load Detection and Quantitation in Plasma of HIV-1-Infected Individuals: A Comparison With Abbott RealTime HIV-1 Assay
    Amendola, Alessandra
    Pisciotta, Maria
    Aleo, Loredana
    Ferraioli, Valeria
    Angeletti, Claudio
    Capobianchi, Maria Rosaria
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (09) : 1535 - 1544
  • [50] Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients
    C Rossi
    PG Balboni
    M Betti
    PC Marconi
    R Bozzini
    MP Grossi
    G Barbanti-Brodano
    A Caputo
    Gene Therapy, 1997, 4 : 1261 - 1269